Skip to content

Anthony Feinstein

4 papers in the library · 33 citations · publishing 2015-2025

Papers

Sort Most recent Most cited

Implementation considerations of key knowledge users for building online mindfulness-based interventions for people with multiple sclerosis.

Disability and Rehabilitation April 16, 2025 Ashvene Sureshkumar, Dorothy Luong, Sarah Munce et al. 1 citation

Mindfulness-based interventions (MBIs) can effectively reduce stress in people with multiple sclerosis (PwMS). Online MBIs address access barriers, but large-scale implementation from the perspectives of key knowledge users remains understudied. This study explored the implementation considerations of PwMS, care partners, MS clinicians and MBI instructors for building online MBIs for PwMS. A...

A systematic review and meta-analysis exploring the efficacy of mindfulness-based interventions on quality of life in people with multiple sclerosis.

Journal of Neurology November 9, 2022 Robert Simpson, Stephanie Posa, Laura Langer et al.

Background: Quality of life (QoL) is commonly impaired among people with multiple sclerosis (PwMS). The aim of this study was to evaluate via meta-analysis the efficacy of Mindfulness-based interventions (MBIs) for improving QoL in PwMS. Methods: Eligible randomized controlled trials (RCTs) were identified via searching six major electronic databases (MEDLINE, EMBASE, CINAHL, Cochrane Central...

Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis

Brain July 3, 2019 Anthony Feinstein, Cecilia Meza, Cristiana Stefan et al. 32 citations

Cognitive dysfunction affects 40-80% of patients with multiple sclerosis. Smoking cannabis may add to these deficits. It is unclear whether coming off cannabis results in cognitive improvement. To address this question, 40 patients with multiple sclerosis who started using cannabis after the onset of multiple sclerosis and who used it for at least 4 days a week over many years were divided by...

What to make of cannabis and cognition in MS: In search of clarity amidst the haze

Multiple Sclerosis Journal December 1, 2015 Anthony Feinstein, Emma Banwell, Bennis Pavisian

Given data showing that cannabis (herbal drug from the Cannabis sativa plant) can impair cognition in healthy subjects, the possibility that it may also do so in people with multiple sclerosis (MS) should be cause for concern. Approximately 20% of people with MS inhale or ingest cannabis for a variety of symptoms, or as a lifestyle choice. In addition, pharmaceutically manufactured cannabis (in...